Opening question: When a peptide ad flashes Swiss “authorisation” language or a Swissmedic-looking screenshot, how do you tell Swissmedic marketing authorisation from clearance for a research peptide?
Short answer: open Swissmedic’s Authorisations page for human medicines and the Swissmedic homepage (Swiss Agency for Therapeutic Products). Swissmedic explains that, in the authorisation procedure, it assesses quality, safety, and effectiveness from submitted scientific documentation and—if criteria are met—grants marketing authorisation and approves professional and patient information. That is Switzerland’s medicine-authorisation pathway, not a badge for research-only catalog vials.
A practical Swissmedic checklist when ads lean on Swiss authorisation framing:
- What authorisation means on Swissmedic’s page: The Authorisations overview states Swissmedic assesses quality, safety, and effectiveness; if criteria are fulfilled it grants marketing authorisation, specifies the method of sale, and approves healthcare-professional and patient information.
- Agency context: Swissmedic presents itself as the Swiss Agency for Therapeutic Products, with public sections for human medicines, veterinary medicines, complementary/herbal medicines, and medical devices. Knowing which silo an ad screenshots matters.
- Screenshot ≠ your vial: Ads may show Swissmedic navigation, SwissPAR-style titles, or “new authorisation” news tiles. Ask whether a specific authorised medicinal product is named, whether the claim is about Swiss marketing authorisation, and whether the research catalog product is even within that system.
- What to open next: Read Swissmedic’s authorisations overview, keep research catalogs separate from national marketing-authorisation registers, and do not treat a Swiss regulator screenshot as dosing or human-use evidence.
None of those steps turns a laboratory research listing into an approved medicine. Company research-only catalogs document laboratory intent and paperwork such as certificates of analysis; they do not create human-use approval. For company facts only—not clinical evidence—Apollo Peptides states products are for laboratory research only, not for human or veterinary use, and describes third-party testing with certificates of analysis.
Bottom line: Use Swissmedic’s public authorisations page to understand what Swiss marketing authorisation involves, then ask whether the ad is citing that process or implying a research peptide is cleared for people. That habit helps you notice overclaiming—it is not advice to buy, inject, or dose any peptide.
By The Everyday Brief · AI-assisted editorial. Drafted with AI research assistance; claims checked against the opened Swissmedic Authorisations and homepage materials on 2026-09-24 PT. No invented studies, quotes, or dosing. Not medical or legal advice.
Sources
1. Swissmedic — Authorisations (human medicines)
2. Swissmedic — Homepage (Swiss Agency for Therapeutic Products)
3. Apollo Peptides (company facts only)
Related reading
How to use Health Canada’s Drug Product Database when ads imply Canadian approval
How to find EMA SmPC and EPAR documents when EU-framed ads imply approved medicines
How to use FDA’s Purple Book when peptide ads flash biologic-looking screenshots